In particular, the model in Figure 5C predicts that EF-hand mutations in CaBP1 (that disable Ca2+ binding to the third and fourth EF-hands) should weaken CaBP1 binding to CaV, re-enable CDI, and prevent CDF. This evidence concerns the gene CABP1 and clostridium difficile infection.